Preterm infants suffer increased risk of acute and chronic respiratory
disorders. In patients with chronic lung disease or severe bronchopul
monary dysplasia, long-term respiratory morbidity and pulmonary dysfun
ction into late childhood and early adulthood have been reported. This
includes symptomatic morbidity (recurrent cough and/or wheeze) and lu
ng function abnormalities such as increased resistance to airflow, air
way hyperresponsiveness, and increased propensity to air-trapping. To
date, no clinically significant association between prematurity and cl
assical atopic asthma has been demonstrated, Therefore, interventions
should primarily focus on the reduction of wheezing disorders and lung
function abnormalities in children horn prematurely. In order to desi
gn interventions in the foetal and early neonatal period or during chi
ldhood the potential risk factors for long-term morbidity need to be c
arefully identified at different age groups: factors which affect pre-
and postnatal lung growth, airway inflammation, viral infections, air
pollution and others. Future research issues should include well-cond
ucted prospective follow-up programmes which will identify major risk
factors in specific populations. Early intervention will provide infor
mation on disease mechanisms and on new prophylactic as well as therap
eutic strategies.